Stay updated on PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial page.

Latest updates to the PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision label in the page footer updated from v3.6.2 to v3.6.3. This reflects a minor platform update to the record history page and does not change the trial data or visible content.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page’s revision label changed from v3.6.0 to v3.6.2, indicating a minor version update on the study history page.SummaryDifference0.1%

- Check31 days agoChange DetectedThe history shows recruitment status updated to 'No longer looking for participants', indicating enrollment has ended for this study. A new revision entry 'Revision: v3.6.0' was added, and the previous revision v3.5.5 was removed.SummaryDifference0.3%

- Check38 days agoChange DetectedThe history page shows a new revision version, changing from v3.5.4 to v3.5.5. This is a metadata update reflecting an updated page version rather than a substantive alteration to the study record.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page’s history view shows the version history for the study record, including past submission dates and status updates. Since no specific changes were supplied, there is no distinct change to summarize beyond the existing history.SummaryDifference0.1%

- Check52 days agoChange DetectedRecord History page received a visual redesign that reorganizes the version list and navigation, while preserving all existing version data. The update improves readability and usability without altering the underlying records.SummaryDifference0.1%

Stay in the know with updates to PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial page.